MedPath

PREhabilitation of CAndidates for REnal Transplantation: A Hybrid Study

Recruiting
Conditions
chronic kidney disease
End-stage renal disease
10029149
Registration Number
NL-OMON53460
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
176
Inclusion Criteria

1. Adult kidney transplant candidates (>=18 years)
2. Listed for kidney transplantation on the UMCG kidney transplant waiting list
at the start of the study or wait listed during the inclusion period (November
2022 - March 2025).

Exclusion Criteria

1. Inability to read and/or speak Dutch
2. Combined organ transplantation (e.g., kidney+pancreas, kidney+liver)
3. In case of living donor kidney transplant: a transplantation planned within
3 months
4. Involved in a lifestyle intervention program

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Frailty will serve as a proxy for overall health status. Therefore, the primary<br /><br>endpoint of this study is change in frailty status as measured by the Tilburg<br /><br>Frailty Indicator. Endpoints will be measured at T0 (baseline assessment), T1<br /><br>(13 weeks after T0) and T2 (26 weeks after T0).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p> Secondary endpoints include changes in physical fitness (hand grip strength,<br /><br>leg muscle strength, functional capacity, nutritional status (BMI, Fat free<br /><br>mass, psychological well-being (fatigue, symptoms of anxiety and depression)<br /><br>and quality of life. Endpoints will be measured at T0 (baseline assessment), T1<br /><br>(13 weeks after T0) and T2 (26 weeks after T0).</p><br>
© Copyright 2025. All Rights Reserved by MedPath